Shu Jin

444 total citations
27 papers, 331 citations indexed

About

Shu Jin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shu Jin has authored 27 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Immunology. Recurrent topics in Shu Jin's work include RNA Interference and Gene Delivery (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Epigenetics and DNA Methylation (3 papers). Shu Jin is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Epigenetics and DNA Methylation (3 papers). Shu Jin collaborates with scholars based in China. Shu Jin's co-authors include Shengbao Li, Qiang Tong, Fei Yao, Hui Long, Qingming Wu, Weiguo Hu, Huan Li, Ren Zhang, Wanxin Liu and Meng Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Letters.

In The Last Decade

Shu Jin

23 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Jin China 11 210 105 64 42 37 27 331
Alina Janney United Kingdom 4 228 1.1× 110 1.0× 43 0.7× 41 1.0× 53 1.4× 4 359
Hyeon‐Gun Jee South Korea 11 276 1.3× 85 0.8× 44 0.7× 35 0.8× 40 1.1× 24 470
Hitendra S. Solanki United States 13 266 1.3× 80 0.8× 103 1.6× 47 1.1× 61 1.6× 26 478
Zhuxian Zhu China 6 211 1.0× 75 0.7× 92 1.4× 21 0.5× 20 0.5× 13 310
Sayed Mostafa Hosseini Iran 10 142 0.7× 106 1.0× 104 1.6× 24 0.6× 83 2.2× 29 336
Joo‐Mi Yi South Korea 12 267 1.3× 65 0.6× 37 0.6× 51 1.2× 33 0.9× 19 419
Ming-Yung Lee Taiwan 9 131 0.6× 79 0.8× 43 0.7× 47 1.1× 42 1.1× 10 336
Iain Ewing United Kingdom 5 95 0.5× 99 0.9× 60 0.9× 35 0.8× 35 0.9× 11 289

Countries citing papers authored by Shu Jin

Since Specialization
Citations

This map shows the geographic impact of Shu Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Jin more than expected).

Fields of papers citing papers by Shu Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Jin. The network helps show where Shu Jin may publish in the future.

Co-authorship network of co-authors of Shu Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Jin. A scholar is included among the top collaborators of Shu Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Jin. Shu Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jingyi, Liwei Fu, Jinglin Chen, et al.. (2025). CXCL13 suppresses liver regeneration through the negative regulation of HGF signaling. Cell Death and Disease. 16(1). 361–361. 1 indexed citations
3.
Zhang, Yue, Yao Ding, Yuhong Liao, Shu Jin, & Yi Gong. (2025). Unlocking the potential of antibody-drug conjugates in cervical cancer: emerging targets and clinical trials. Frontiers in Pharmacology. 16. 1636120–1636120.
4.
Jin, Shu, et al.. (2024). Microseismic Event Recognition and Transfer Learning Based on Convolutional Neural Network and Attention Mechanisms. Applied Geophysics. 22(4). 1220–1232. 3 indexed citations
5.
Liu, Xiaobo, et al.. (2024). TET2 Is Downregulated in Early Esophageal Squamous Cell Carcinoma and Promotes Esophageal Squamous Cell Malignant Behaviors. Digestive Diseases and Sciences. 69(7). 2462–2476. 1 indexed citations
7.
Jin, Shu, et al.. (2023). Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1. Open Life Sciences. 18(1). 20220554–20220554. 2 indexed citations
8.
Zhu, Rui, Xiaoying Huang, Fei Yao, et al.. (2023). Metabolomic analysis of gut metabolites in patients with colorectal cancer: Association with disease development and outcome. Oncology Letters. 26(2). 358–358. 10 indexed citations
9.
Zhao, Qun, Jian Guo, Yun Bi, et al.. (2021). RIPK3 Suppresses the Progression of Spontaneous Intestinal Tumorigenesis. Frontiers in Oncology. 11. 664927–664927. 15 indexed citations
10.
Zhao, Qun, Jian Guo, Yun Bi, et al.. (2021). MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. International Journal of Biological Sciences. 17(3). 869–881. 13 indexed citations
11.
Zhao, Qun, Jian Guo, Guizhen Wang, et al.. (2021). CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling. Cancer Letters. 511. 1–14. 15 indexed citations
12.
Wang, Huan, Lei Tu, Ying Li, et al.. (2020). The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID‐19 Epidemic. Journal of Immunology Research. 2020(1). 2847316–2847316. 10 indexed citations
13.
Liu, Wanxin, Ren Zhang, Huan Li, et al.. (2020). Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing. BioMed Research International. 2020(1). 7828392–7828392. 106 indexed citations
14.
Liu, Xiaobo, et al.. (2019). <p>Serum pepsinogen assay is not recommended for the diagnosis of esophageal squamous cell carcinoma: a systematic review and meta-analysis</p>. Cancer Management and Research. Volume 11. 5643–5654. 3 indexed citations
16.
Wang, Yan, Shu Jin, Weiping Deng, et al.. (2012). Up-regulation of P-glycoprotein is involved in the increased paclitaxel resistance in human esophageal cancer radioresistant cells. Scandinavian Journal of Gastroenterology. 47(7). 802–808. 28 indexed citations
17.
Zhang, Weiguo, Qiang Tong, Zihua Chen, et al.. (2010). The usefulness of endoscopic ultrasound in the differential diagnosis between benign and malignant gastric ulcer. Scandinavian Journal of Gastroenterology. 45(9). 1093–1096. 2 indexed citations
18.
Tong, Qiang, Weiguo Zhang, Shu Jin, Shengbao Li, & Zihua Chen. (2010). The relationship between p27kip1expression and the change of radiosensitivity of esophageal carcinoma cells. Scandinavian Journal of Gastroenterology. 46(2). 173–176. 7 indexed citations
19.
Wang, Qingfei, Meixing Li, Ying Wang, et al.. (2008). RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Letters. 269(1). 127–138. 31 indexed citations
20.
Xie, Guohua, Shujun Wang, Ying Wang, et al.. (2008). Fas Ligand gene transfer enhances the survival of tissue-engineered chondrocyte allografts in mini-pigs. Transplant Immunology. 19(2). 145–151. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026